SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001626199-19-000029
Filing Date
2019-04-18
Accepted
2019-04-18 16:31:59
Documents
3
Period of Report
2019-04-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-k_20190418.htm 8-K 38289
2 EXHIBIT 99.1 alpn-ex991_20190418.htm EX-99.1 14617
3 exhibit99120190418alp_image1.jpg GRAPHIC 15826
  Complete submission text file 0001626199-19-000029.txt   76274
Mailing Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119
Business Address 201 ELLIOTT AVE. WEST, SUITE 230 SEATTLE WA 98119 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 19756279
SIC: 2834 Pharmaceutical Preparations